Skip to main content

TRANSACT TECHNOLOGIES INC Value Stock - Dividend - Research Selection

Transact technologies

ISIN: US8929181035 , WKN: 910968

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

TransAct Technologies Incorporated designs, develops, assembles, and markets transaction-based and specialty printers and terminals in the United States and internationally. It offers thermal, inkjet, and impact printers and terminals to generate labels and transaction records, such as receipts, tickets, coupons, register journals, and other documents, as well as printed logging and plotting of data. The company also provides consumable products, including inkjet cartridges, ribbons, receipt papers, color thermal papers, food safety labels, and other printing supplies, as well as replacement parts; maintenance, repair, and testing services; and refurbished printers. In addition, it offers EPICENTRAL print system, a software solution that enables casino operators to create promotional coupons and marketing messages, and print them at the slot machine; and technical support services, as well as spare parts and accessories. Further, the company provides AccuDate terminals for the restaurant solutions market combine hardware and software in a device that includes an operating system, touchscreen, and one or two thermal print mechanisms. The company markets its products under the AccuDate, Epic, EPICENTRAL, Ithaca, Responder, and Printrex brand names for restaurant, point of sale automation and banking, casino and gaming, lottery, mobile, oil and gas, and hospitality markets, as well as government. It sells its products to original equipment manufacturers, value-added resellers, and distributors, as well as directly and online to end-users. TransAct Technologies Incorporated was founded in 1996 and is headquartered in Hamden, Connecticut.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Laughing Water Capital Q1 2024 Letter

2024-04-18
Laughing Water Capital returned approximately 8.4% in the first quarter of 2023 after all fees and expenses. Click here to read the full letter.

3 Tech Stocks to Buy to Triple Your Investment by 2025

2024-04-12
Tech stocks have been on an absolute tear over the past two and a half decades, handily outperforming all other sectors. And with artificial intelligence now supercharging these companies, I believe the tech sector is poised to continue seeing accelerating growth over the next 20 years as well. That’s why it’s critical to have meaningful exposure to top tech stocks in your portfolio, if you want to maximize returns. However, that’s only part of the equation. While tech giants can provide market-

TransAct Technologies Incorporated (NASDAQ:TACT) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

2024-04-03
TransAct Technologies (NASDAQ:TACT) has had a rough three months with its share price down 29%. However, the company's...

Warning: TACT is at high risk of performing badly

2024-03-20
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

TransAct Technologies (NASDAQ:TACT) shareholders have endured a 43% loss from investing in the stock three years ago

2024-03-13
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its...

TransAct Technologies Incorporated (NASDAQ:TACT) Q4 2023 Earnings Call Transcript

2024-03-13
TransAct Technologies Incorporated (NASDAQ:TACT) Q4 2023 Earnings Call Transcript March 12, 2024 TransAct Technologies Incorporated misses on earnings expectations. Reported EPS is $-0.01 EPS, expectations were $-0.00583. TransAct Technologies Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, welcome […]

12 Information Technology Stocks Moving In Wednesday's Intraday Session

2024-03-13
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Q4 2023 TransAct Technologies Inc Earnings Call

2024-03-13
Q4 2023 TransAct Technologies Inc Earnings Call

Analysts Offer Insights on Technology Companies: Envestnet (ENV), Transact Technologies (TACT) and FiscalNote Holdings (NOTE)

2024-03-13
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

TransAct Technologies price target lowered by $1 at Craig-Hallum, here's why

2024-03-13
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.